Skip Navigation


NDT Advance Access first published online on September 19, 2009
This version published online on October 5, 2009

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp494
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/12/3882    most recent
gfp494v2
gfp494v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wollanka, H.
Right arrow Articles by Giersig, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wollanka, H.
Right arrow Articles by Giersig, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



NSF after Gadovist exposure: a case report and hypothesis of NSF development

Helmut Wollanka1, Werner Weidenmaier2 and Cecylia Giersig3

1 SRH Hospital Karlsbad-Langensteinbach Ltd, Centre for Neurology and Early Rehabilitation, Academic Hospital at Heidelberg University, Heidelberg 2 Radiology and Nuclear Medicine, Mühlacker 3 Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany

Correspondence and offprint requests to: Cecylia Giersig; E-mail: giersig{at}bfarm.de



  Abstract

So far no cases of nephrogenic systemic fibrosis (NSF) have been published on macrocyclical gadolinium-based contrast media (Gd-CM), assumed as low NSF risk CM due to their complex stability. In our haemodialysis-dependent patient, the first symptoms indicating NSF appeared about 16 months after the exposure to Gadovist, a macrocyclical Gd-CM, and 1 month after x-ray angiography with iodinated CM (Ultravist). This indicates that in addition to excretory renal failure and Gd-CM exposure, the loss of biosynthetic renal function could be essential for NSF development. A hypothesis of possible pathways involved in the development of NSF is presented.

Keywords: FGF23-Klotho axis; hypothesis of NSF development; macrocyclical gadolinium-based contrast media; NSF; case report


The original version was incorrect. The word macrocyclical has been removed from the Background section.

Received for publication: 29. 7.09
Accepted in revised form: 24. 8.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.